Charles River Laboratories International, Inc. (CRL) vs Quest Diagnostics Incorporated (DGX)
- Charles River Laboratories International, Inc. CRL 299.77 −2.11%
- Quest Diagnostics Incorporated DGX 235.00 −1.74%
Charles River Laboratories International, Inc. and Quest Diagnostics Incorporated are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $26.4B against $14.6B — 1.8× the size. Charles River Laboratories International, Inc. has negative trailing earnings, so its P/E is not meaningful; Quest Diagnostics Incorporated trades at 24.6×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.87% against −0.74%. Quest Diagnostics Incorporated has the higher net margin (9.15% vs −5.96%) and the higher return on invested capital (7.94% vs 1.07%). Across the 21 metrics below, Quest Diagnostics Incorporated leads on 19 and Charles River Laboratories International, Inc. on 2.
Valuation
Profitability
| Metric | CRL | DGX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 32.67% | 33.11% | 50.89% |
| Operating margin | 2.25% | 14.10% | (8.57%) |
| Net margin | (5.96%) | 9.15% | (6.37%) |
| Free cash flow margin | 9.27% | 11.67% | 0.00% |
| Return on equity | (7.69%) | 14.03% | (2.92%) |
| Return on assets | (3.16%) | 6.43% | (6.71%) |
| Return on invested capital | 1.07% | 7.94% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack